The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kalif Eliyahu Sharon since 2021.
This trader's CIK number is 1798443.
At the time of last reporting, Kalif Eliyahu Sharon was the EVP, Chief Financial Officer of Teva Pharmaceutical Industries Ltd. (stock ticker symbol TEVA).
Also see all insider trading activities at Teva Pharmaceutical Industries Ltd.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | TEVA | 0 | $0 | 111,525 | $1,855,953 | 311,122 | $0 |
| 2024 | TEVA | 0 | $0 | 0 | $0 | 25,060 | $0 |
| 2023 | TEVA | 0 | $0 | 35,125 | $341,906 | 188,294 | $0 |
| 2022 | TEVA | 0 | $0 | 55,500 | $558,718 | 46,446 | $0 |
| 2021 | TEVA | 0 | $0 | 0 | $0 | 18,430 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-12 | TEVA | Sale | 55,775 | 17.08 | 952,469 |
| 2025-03-05 | TEVA | Option Ex | 21,390 | .00 | 0 |
| 2025-03-04 | TEVA | Option Ex | 239,932 | .00 | 0 |
| 2025-02-28 | TEVA | Sale | 55,750 | 16.21 | 903,484 |
| 2025-03-03 | TEVA | Option Ex | 49,800 | .00 | 0 |
| 2024-02-28 | TEVA | Option Ex | 18,430 | .00 | 0 |
| 2024-02-13 | TEVA | Option Ex | 6,630 | .00 | 0 |
| 2023-08-07 | TEVA | Sale | 35,125 | 9.73 | 341,906 |
| 2023-03-04 | TEVA | Option Ex | 33,512 | .00 | 0 |
| 2023-03-05 | TEVA | Option Ex | 21,387 | .00 | 0 |
| 2023-02-28 | TEVA | Option Ex | 63,383 | .00 | 0 |
| 2023-02-28 | TEVA | Option Ex | 63,383 | .00 | 0 |
| 2023-02-13 | TEVA | Option Ex | 6,629 | .00 | 0 |
| 2022-08-22 | TEVA | Sale | 55,500 | 10.07 | 558,718 |
| 2022-03-05 | TEVA | Option Ex | 21,387 | .00 | 0 |
| 2022-02-28 | TEVA | Option Ex | 18,430 | .00 | 0 |
| 2022-02-13 | TEVA | Option Ex | 6,629 | .00 | 0 |
| 2021-02-28 | TEVA | Option Ex | 18,430 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kalif Eliyahu Sharon (EVP, Chief Financial Officer of Teva Pharmaceutical Industries Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.